SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Reata Pharmaceuticals Q1 EPS $(1.470) Beats $(1.980) Estimate, Sales $1.353M Miss $2.040M Estimate

Reata Pharmaceuticals (NASDAQ:RETA) reported quarterly losses of $(1.470) per share which beat the analyst consensus estimate of $(1.980) by 25.76 percent. This is a 50 percent decrease over losses of $(0.980) per share

Benzinga · 05/11/2020 20:10

Reata Pharmaceuticals (NASDAQ:RETA) reported quarterly losses of $(1.470) per share which beat the analyst consensus estimate of $(1.980) by 25.76 percent. This is a 50 percent decrease over losses of $(0.980) per share from the same period last year. The company reported quarterly sales of $1.353 million which missed the analyst consensus estimate of $2.040 million by 33.68 percent. This is a 82.59 percent decrease over sales of $7.770 million the same period last year.